VEGF promotes cardiac stem cells differentiation into vascular endothelial cells via the PI3K/Akt signaling pathway

被引:28
作者
Xiao, Nuan [1 ]
Qi, Xiao-Yong [1 ,2 ]
Tang, Lu-Ning [1 ]
Tan, Li-Li [1 ]
Chen, Ya-Qing [1 ]
Zhao, Hong-Mei [1 ]
机构
[1] Hebei Med Univ, Dept Internal Med, Shijiazhuang 050017, Peoples R China
[2] Hebei Gen Hosp, Dept Cardiol 1, Shijiazhuang, Peoples R China
关键词
cardiac stem cells; PI3K/Akt signaling pathway; rat; vascular endothelial cells; GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; CARDIOVASCULAR-DISEASE; ORGAN GROWTH; AKT; ACTIVATION; MECHANISMS; DROSOPHILA;
D O I
10.3109/21691401.2013.837473
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Recent research suggested that cardiac stem cells (CSCs) may have the clinical application for cardiac repair. However, their characteristics and the regulatory mechanisms of their growth and differentiation have not been fully investigated. Vascular endothelial growth factor (VEGF, VEGF-A) is a major regulator of physiological and pathological angiogenesis. But the homing role of VEGF for CSCs is unclear. In this report, CSCs were isolated, purified, and expanded in vitro from rat heart. VEGF, SU5416 (VEGF receptor blocker), and Wortmannin (PI3K/Akt signaling pathway inhibitor) were used for differentiation into vascular endothelial cells (VECs). Real-time qPCR was selected to confirm the role of PI3K/Akt signaling pathway in VECs differentiation from rat CSCs. The result of real-time qPCR demonstrated that PI3K/Akt signaling pathway plays an important role in rat CSCs differentiated into VECs. So, our research provides a theoretical basis and experimental evidence for therapeutic application of rat CSCs to treat cardiac repair.
引用
收藏
页码:400 / 405
页数:6
相关论文
共 22 条
[1]   Identification and biological characterization of chicken embryonic cardiac progenitor cells [J].
Bai, C. ;
Hou, L. ;
Zhang, M. ;
Wang, L. ;
Guan, W. ;
Ma, Y. .
CELL PROLIFERATION, 2013, 46 (02) :232-242
[2]   Shear stress stimulates phosphorylation of protein kinase A substrate proteins including endothelial nitric oxide synthase in endothelial cells. (Retraction of vol 38, pg 63, 2006) [J].
Boo, Y. C. .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2006, 38 (04) :453-453
[3]   Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation [J].
Dimmeler, S ;
Fleming, I ;
Fisslthaler, B ;
Hermann, C ;
Busse, R ;
Zeiher, AM .
NATURE, 1999, 399 (6736) :601-605
[4]   Role of vascular endothelial growth factor in regulation of physiological angiogenesis [J].
Ferrara, N .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1358-C1366
[5]   Therapeutic angiogenesis for ischemic cardiovascular disease [J].
Freedman, SB ;
Isner, JM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (03) :379-393
[6]   Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner [J].
Fujio, Y ;
Walsh, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16349-16354
[7]   Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [J].
Fulton, D ;
Gratton, JP ;
McCabe, TJ ;
Fontana, J ;
Fujio, Y ;
Walsh, K ;
Franke, TF ;
Papapetropoulos, A ;
Sessa, WC .
NATURE, 1999, 399 (6736) :597-601
[8]   Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway -: Requirement for Flk-1/KDR activation [J].
Gerber, HP ;
McMurtrey, A ;
Kowalski, J ;
Yan, MH ;
Keyt, BA ;
Dixit, V ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30336-30343
[9]  
HOUCK KA, 1992, J BIOL CHEM, V267, P26031
[10]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A SECRETED ANGIOGENIC MITOGEN [J].
LEUNG, DW ;
CACHIANES, G ;
KUANG, WJ ;
GOEDDEL, DV ;
FERRARA, N .
SCIENCE, 1989, 246 (4935) :1306-1309